New York State Common Retirement Fund
HZNP

New York State Common Retirement Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

New York State Common Retirement Fund’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-186,470
Closed -$21.6M – 3296
2023
Q3 		$21.6M Sell
186,470
-109,800
-37% -$11.8M 0.03% 471
2023
Q2 		$30.5M Sell
296,270
-11,318
-4% -$1.19M 0.04% 405
2023
Q1 		$33.6M Sell
307,588
-13,091
-4% -$1.45M 0.05% 367
2022
Q4 		$36.5M Buy
320,679
+79,947
+33% +$6.64M 0.05% 330
2022
Q3 		$14.9M Sell
240,732
-48,662
-17% -$3.4M 0.02% 651
2022
Q2 		$23.1M Sell
289,394
-27,699
-9% -$2.62M 0.03% 482
2022
Q1 		$33.4M Buy
317,093
+49,224
+18% +$4.8M 0.04% 426
2021
Q4 		$28.9M Sell
267,869
-1,318
-0.5% -$144K 0.03% 495
2021
Q3 		$29.5M Buy
269,187
+5,855
+2% +$608K 0.03% 497
2021
Q2 		$24.7M Buy
263,332
+2,623
+1% +$241K 0.03% 588
2021
Q1 		$24M Sell
260,709
-23,247
-8% -$1.96M 0.03% 584
2020
Q4 		$20.8M Sell
283,956
-32,090
-10% -$2.39M 0.02% 626
2020
Q3 		$24.6M Sell
316,046
-9,490
-3% -$653K 0.03% 514
2020
Q2 		$18.1M Sell
325,536
-60,446
-16% -$2.59M 0.02% 623
2020
Q1 		$11.4M Sell
385,982
-40,337
-9% -$1.36M 0.02% 731
2019
Q4 		$15.4M Sell
426,319
-27,939
-6% -$857K 0.02% 771
2019
Q3 		$12.4M Buy
454,258
+34,397
+8% +$889K 0.02% 860
2019
Q2 		$10.1M Buy
419,861
+161,020
+62% +$4.08M 0.01% 969
2019
Q1 		$6.84M Buy
258,841
+24,250
+10% +$575K 0.01% 1105
2018
Q4 		$4.58M Sell
234,591
-16,600
-7% -$325K 0.01% 1223
2018
Q3 		$4.92M Sell
251,191
-98,800
-28% -$1.88M 0.01% 1279
2018
Q2 		$5.8M Buy
349,991
+60,800
+21% +$927K 0.01% 1213
2018
Q1 		$4.11M Buy
289,191
+14,790
+5% +$218K 0.01% 1302
2017
Q4 		$4.01M Buy
274,401
+35,788
+15% +$503K ﹤0.01% 1317
2017
Q3 		$3.03M Buy
238,613
+7,000
+3% +$89K ﹤0.01% 1427
2017
Q2 		$2.75M Sell
231,613
-112,142
-33% -$1.39M ﹤0.01% 1523
2017
Q1 		$5.08M Sell
343,755
-186,544
-35% -$3.02M 0.01% 1247
2016
Q4 		$8.58M Buy
530,299
+82,577
+18% +$1.5M 0.01% 1010
2016
Q3 		$8.12M Sell
447,722
-53,107
-11% -$1.04M 0.01% 1021
2016
Q2 		$8.25M Buy
500,829
+116,381
+30% +$1.88M 0.01% 1024
2016
Q1 		$6.37M Buy
384,448
+66,786
+21% +$1.17M 0.01% 1113
2015
Q4 		$6.88M Sell
317,662
-58,551
-16% -$1.14M 0.01% 1088
2015
Q3 		$7.46M Sell
376,213
-32,823
-8% -$1.04M 0.01% 1041
2015
Q2 		$14.2M Sell
409,036
-264,619
-39% -$8.08M 0.02% 762
2015
Q1 		$17.5M Sell
673,655
-138,620
-17% -$2.54M 0.03% 634
2014
Q4 		$10.5M Buy
812,275
+44,125
+6% +$552K 0.02% 853
2014
Q3 		$9.43M Sell
768,150
-251,095
-25% -$2.92M 0.01% 922
2014
Q2 		$16.1M Buy
1,019,245
+584,620
+135% +$8.34M 0.02% 729
2014
Q1 		$6.57M Buy
434,625
+57,500
+15% +$649K 0.01% 1105
2013
Q4 		$2.87M Buy
+377,125
New +$2.03M ﹤0.01% 1468

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York State Common Retirement Fund's HZNP Position: Q4 2023 in Review

New York State Common Retirement Fund sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 186,470 shares — an estimated $21.6M sold.

New York State Common Retirement Fund first reported a position in HZNP in Q4 2013 and held it in 40 quarters. The position peaked at $36.5M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • New York State Common Retirement Fund reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 186,470 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $21.6M.
  • New York State Common Retirement Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 40 quarters.
  • New York State Common Retirement Fund's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $36.5M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on New York State Common Retirement Fund's 13F filing for Q4 2023, filed 1 Feb 2024.